| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ondansetron hydrochloride |
Is a |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ondansetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| ondansetron 2 mg/mL, ampoule de 2 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron 8mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron 8mg/4mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron 4mg/5mL sugar free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron 4mg wafer (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron 8mg wafer (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron 0.64mg injection solution 50mL ampule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ondansetron in oropharyngeal dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible film |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible film (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ondansetron in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron 8mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron 8mg tablet (substance) |
Has basis of strength substance (attribute) |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository (clinical drug) |
Has precise active ingredient |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron 8mg tablet (substance) |
Has precise active ingredient |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron hydrochloride |
Is modification of (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ondansetron-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron (as ondansetron hydrochloride) 800 microgram/mL oral solution |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/2 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/4 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron (as ondansetron hydrochloride) 2 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible film |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible film (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron 4 mg oral lyophilisate |
Has precise active ingredient |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ondansetron 4 mg oral lyophilisate |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron 8 milligram/1 each conventional release oral lyophilisate (clinical drug) |
Has precise active ingredient |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron 8 milligram/1 each conventional release oral lyophilisate (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ondansetron (as ondansetron hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ondansetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]